Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
Sell
37
RSPH Quote, Financials, Valuation and Earnings
Last price:
$29.69
Seasonality move
:
2.86%
Day range:
$29.51 - $29.75
52-week range:
$28.92 - $32.85
Dividend yield:
0.7%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
73.9K
Avg. volume:
92.8K
1-year change:
-0.13%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | -- | -- | -- | -- |
|
BBH
VanEck Biotech ETF
|
-- | -- | -- | -- | -- |
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
IHE
iShares US Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
IHF
iShares US Healthcare Providers ETF
|
-- | -- | -- | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
$29.70 | -- | -- | -- | $0.06 | 0.7% | -- |
|
BBH
VanEck Biotech ETF
|
$159.19 | -- | -- | -- | $1.25 | 0.79% | -- |
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
$27.39 | -- | -- | -- | $0.13 | 1.64% | -- |
|
IHE
iShares US Pharmaceuticals ETF
|
$66.82 | -- | -- | -- | $0.21 | 1.7% | -- |
|
IHF
iShares US Healthcare Providers ETF
|
$48.68 | -- | -- | -- | $0.10 | 0.85% | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
$83.65 | -- | -- | -- | $0.22 | 0.96% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | 1.335 | -- | -- |
|
BBH
VanEck Biotech ETF
|
-- | 1.127 | -- | -- |
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
-- | 1.073 | -- | -- |
|
IHE
iShares US Pharmaceuticals ETF
|
-- | 1.040 | -- | -- |
|
IHF
iShares US Healthcare Providers ETF
|
-- | 1.288 | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | 0.832 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | -- | -- | -- | -- | -- |
|
BBH
VanEck Biotech ETF
|
-- | -- | -- | -- | -- | -- |
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
IHE
iShares US Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
IHF
iShares US Healthcare Providers ETF
|
-- | -- | -- | -- | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
Invesco S&P 500 Eql Wght Health Care ETF vs. Competitors
-
Which has Higher Returns RSPH or BBH?
VanEck Biotech ETF has a net margin of -- compared to Invesco S&P 500 Eql Wght Health Care ETF's net margin of --. Invesco S&P 500 Eql Wght Health Care ETF's return on equity of -- beat VanEck Biotech ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- BBHVanEck Biotech ETF-- -- -- -
What do Analysts Say About RSPH or BBH?
Invesco S&P 500 Eql Wght Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand VanEck Biotech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P 500 Eql Wght Health Care ETF has higher upside potential than VanEck Biotech ETF, analysts believe Invesco S&P 500 Eql Wght Health Care ETF is more attractive than VanEck Biotech ETF.
Company Buy Ratings Hold Ratings Sell Ratings RSPHInvesco S&P 500 Eql Wght Health Care ETF0 0 0 BBHVanEck Biotech ETF0 0 0 -
Is RSPH or BBH More Risky?
Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.863, which suggesting that the stock is 13.707% less volatile than S&P 500. In comparison VanEck Biotech ETF has a beta of 0.727, suggesting its less volatile than the S&P 500 by 27.303%.
-
Which is a Better Dividend Stock RSPH or BBH?
Invesco S&P 500 Eql Wght Health Care ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.7%. VanEck Biotech ETF offers a yield of 0.79% to investors and pays a quarterly dividend of $1.25 per share. Invesco S&P 500 Eql Wght Health Care ETF pays -- of its earnings as a dividend. VanEck Biotech ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RSPH or BBH?
Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues are --, which are smaller than VanEck Biotech ETF quarterly revenues of --. Invesco S&P 500 Eql Wght Health Care ETF's net income of -- is lower than VanEck Biotech ETF's net income of --. Notably, Invesco S&P 500 Eql Wght Health Care ETF's price-to-earnings ratio is -- while VanEck Biotech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P 500 Eql Wght Health Care ETF is -- versus -- for VanEck Biotech ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- -- BBHVanEck Biotech ETF-- -- -- --
-
Which has Higher Returns RSPH or FTXH?
First Trust Nasdaq Pharmaceuticals ETF has a net margin of -- compared to Invesco S&P 500 Eql Wght Health Care ETF's net margin of --. Invesco S&P 500 Eql Wght Health Care ETF's return on equity of -- beat First Trust Nasdaq Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- FTXHFirst Trust Nasdaq Pharmaceuticals ETF-- -- -- -
What do Analysts Say About RSPH or FTXH?
Invesco S&P 500 Eql Wght Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust Nasdaq Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P 500 Eql Wght Health Care ETF has higher upside potential than First Trust Nasdaq Pharmaceuticals ETF, analysts believe Invesco S&P 500 Eql Wght Health Care ETF is more attractive than First Trust Nasdaq Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings RSPHInvesco S&P 500 Eql Wght Health Care ETF0 0 0 FTXHFirst Trust Nasdaq Pharmaceuticals ETF0 0 0 -
Is RSPH or FTXH More Risky?
Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.863, which suggesting that the stock is 13.707% less volatile than S&P 500. In comparison First Trust Nasdaq Pharmaceuticals ETF has a beta of 0.658, suggesting its less volatile than the S&P 500 by 34.157%.
-
Which is a Better Dividend Stock RSPH or FTXH?
Invesco S&P 500 Eql Wght Health Care ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.7%. First Trust Nasdaq Pharmaceuticals ETF offers a yield of 1.64% to investors and pays a quarterly dividend of $0.13 per share. Invesco S&P 500 Eql Wght Health Care ETF pays -- of its earnings as a dividend. First Trust Nasdaq Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RSPH or FTXH?
Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues are --, which are smaller than First Trust Nasdaq Pharmaceuticals ETF quarterly revenues of --. Invesco S&P 500 Eql Wght Health Care ETF's net income of -- is lower than First Trust Nasdaq Pharmaceuticals ETF's net income of --. Notably, Invesco S&P 500 Eql Wght Health Care ETF's price-to-earnings ratio is -- while First Trust Nasdaq Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P 500 Eql Wght Health Care ETF is -- versus -- for First Trust Nasdaq Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- -- FTXHFirst Trust Nasdaq Pharmaceuticals ETF-- -- -- --
-
Which has Higher Returns RSPH or IHE?
iShares US Pharmaceuticals ETF has a net margin of -- compared to Invesco S&P 500 Eql Wght Health Care ETF's net margin of --. Invesco S&P 500 Eql Wght Health Care ETF's return on equity of -- beat iShares US Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- IHEiShares US Pharmaceuticals ETF-- -- -- -
What do Analysts Say About RSPH or IHE?
Invesco S&P 500 Eql Wght Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P 500 Eql Wght Health Care ETF has higher upside potential than iShares US Pharmaceuticals ETF, analysts believe Invesco S&P 500 Eql Wght Health Care ETF is more attractive than iShares US Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings RSPHInvesco S&P 500 Eql Wght Health Care ETF0 0 0 IHEiShares US Pharmaceuticals ETF0 0 0 -
Is RSPH or IHE More Risky?
Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.863, which suggesting that the stock is 13.707% less volatile than S&P 500. In comparison iShares US Pharmaceuticals ETF has a beta of 0.656, suggesting its less volatile than the S&P 500 by 34.431%.
-
Which is a Better Dividend Stock RSPH or IHE?
Invesco S&P 500 Eql Wght Health Care ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.7%. iShares US Pharmaceuticals ETF offers a yield of 1.7% to investors and pays a quarterly dividend of $0.21 per share. Invesco S&P 500 Eql Wght Health Care ETF pays -- of its earnings as a dividend. iShares US Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RSPH or IHE?
Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues are --, which are smaller than iShares US Pharmaceuticals ETF quarterly revenues of --. Invesco S&P 500 Eql Wght Health Care ETF's net income of -- is lower than iShares US Pharmaceuticals ETF's net income of --. Notably, Invesco S&P 500 Eql Wght Health Care ETF's price-to-earnings ratio is -- while iShares US Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P 500 Eql Wght Health Care ETF is -- versus -- for iShares US Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- -- IHEiShares US Pharmaceuticals ETF-- -- -- --
-
Which has Higher Returns RSPH or IHF?
iShares US Healthcare Providers ETF has a net margin of -- compared to Invesco S&P 500 Eql Wght Health Care ETF's net margin of --. Invesco S&P 500 Eql Wght Health Care ETF's return on equity of -- beat iShares US Healthcare Providers ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- IHFiShares US Healthcare Providers ETF-- -- -- -
What do Analysts Say About RSPH or IHF?
Invesco S&P 500 Eql Wght Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Healthcare Providers ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P 500 Eql Wght Health Care ETF has higher upside potential than iShares US Healthcare Providers ETF, analysts believe Invesco S&P 500 Eql Wght Health Care ETF is more attractive than iShares US Healthcare Providers ETF.
Company Buy Ratings Hold Ratings Sell Ratings RSPHInvesco S&P 500 Eql Wght Health Care ETF0 0 0 IHFiShares US Healthcare Providers ETF0 0 0 -
Is RSPH or IHF More Risky?
Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.863, which suggesting that the stock is 13.707% less volatile than S&P 500. In comparison iShares US Healthcare Providers ETF has a beta of 0.765, suggesting its less volatile than the S&P 500 by 23.516%.
-
Which is a Better Dividend Stock RSPH or IHF?
Invesco S&P 500 Eql Wght Health Care ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.7%. iShares US Healthcare Providers ETF offers a yield of 0.85% to investors and pays a quarterly dividend of $0.10 per share. Invesco S&P 500 Eql Wght Health Care ETF pays -- of its earnings as a dividend. iShares US Healthcare Providers ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RSPH or IHF?
Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues are --, which are smaller than iShares US Healthcare Providers ETF quarterly revenues of --. Invesco S&P 500 Eql Wght Health Care ETF's net income of -- is lower than iShares US Healthcare Providers ETF's net income of --. Notably, Invesco S&P 500 Eql Wght Health Care ETF's price-to-earnings ratio is -- while iShares US Healthcare Providers ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P 500 Eql Wght Health Care ETF is -- versus -- for iShares US Healthcare Providers ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- -- IHFiShares US Healthcare Providers ETF-- -- -- --
-
Which has Higher Returns RSPH or PJP?
Invesco Pharmaceuticals ETF has a net margin of -- compared to Invesco S&P 500 Eql Wght Health Care ETF's net margin of --. Invesco S&P 500 Eql Wght Health Care ETF's return on equity of -- beat Invesco Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- PJPInvesco Pharmaceuticals ETF-- -- -- -
What do Analysts Say About RSPH or PJP?
Invesco S&P 500 Eql Wght Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P 500 Eql Wght Health Care ETF has higher upside potential than Invesco Pharmaceuticals ETF, analysts believe Invesco S&P 500 Eql Wght Health Care ETF is more attractive than Invesco Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings RSPHInvesco S&P 500 Eql Wght Health Care ETF0 0 0 PJPInvesco Pharmaceuticals ETF0 0 0 -
Is RSPH or PJP More Risky?
Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.863, which suggesting that the stock is 13.707% less volatile than S&P 500. In comparison Invesco Pharmaceuticals ETF has a beta of 0.580, suggesting its less volatile than the S&P 500 by 42.037%.
-
Which is a Better Dividend Stock RSPH or PJP?
Invesco S&P 500 Eql Wght Health Care ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.7%. Invesco Pharmaceuticals ETF offers a yield of 0.96% to investors and pays a quarterly dividend of $0.22 per share. Invesco S&P 500 Eql Wght Health Care ETF pays -- of its earnings as a dividend. Invesco Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RSPH or PJP?
Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues are --, which are smaller than Invesco Pharmaceuticals ETF quarterly revenues of --. Invesco S&P 500 Eql Wght Health Care ETF's net income of -- is lower than Invesco Pharmaceuticals ETF's net income of --. Notably, Invesco S&P 500 Eql Wght Health Care ETF's price-to-earnings ratio is -- while Invesco Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P 500 Eql Wght Health Care ETF is -- versus -- for Invesco Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- -- PJPInvesco Pharmaceuticals ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is down 7.51% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 1.83% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is down 3.46% over the past day.
